JPRN-UMIN000037041招募中未知
Multicenter Collaborative Research on Molecularly Targeted Drug Therapy for Advanced Hepatocellular Carcinoma - Multicenter Collaborative Research on Molecularly Targeted Drug Therapy for Advanced Hepatocellular Carcinoma
ara Medical University Third Department of Internal Medicine0 个研究点目标入组 100 人开始时间: 2019年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are allergic to molecularly targeted drugs Patients who were able to confirm their intention to refuse participation
研究者
相似试验
已完成
不适用
DS-ScreeGastric, gastroesophageal junction and colorectal cancersJPRN-jRCT1080223325DAIICHI SANKYO Co.,Ltd.700
招募中
Unknown
Multicenter study to characterize the molecular genetic features of exceptional response to radiotherapyCancers treated with radiotherapyJPRN-UMIN000049867ational Cancer Center50
招募中
1 期
An Imaging Phase I B Study Evaluating MK-0646 in Combination with Erlotinib for Patients with Advanced Non-Small Cell Lung CancerCTRI/2009/091/000139Merck & Co., Inc. One Merck DriveP.O. Box 100Whitehouse Station, NJ, 08889-0100, U.S.A.106
招募中
不适用
Multi-institutional collaborative study on antigen-positive red blood cells (RBCs) transfusion for the patients who have corresponding irregular RBC antibodiesPatients having RBC irregular antibodies and received corresponding antigen-positive RBC transfusionJPRN-UMIN000037218Japan Erythrocyte Irregular Antibody Study Group1,000
尚未招募
不适用
iver protective drug action of homoeopathic preparation of Myrica cerifera 3C on Non alcoholic fatty liver diseaseCTRI/2022/02/040009Dr Raja Manoharan